01—Abstract
Summary
Summary of the 10-K filed February 27, 2015. Cited figures are marked; the original filing is the authoritative source.
Omega Healthcare Investors, Inc. ("Omega") is a self-administered REIT that provides lease and mortgage financing to operators of skilled nursing facilities (SNFs), and to a lesser extent assisted living and other healthcare facilities.
As of December 31, 2014, its portfolio included 568 healthcare facilities in 38 states operated by 50 third-party operators, with gross investments of approximately $4.4 billiona. Total operating revenues rose to $504.8 million in 2014 from $418.7 million in 2013, and net income available to common stockholders was $221.3 million, or $1.74 per diluted share, compared with $172.5 million in 2013. Funds from operations available to common stockholders were $345.4 million, versus $302.7 million in 2013.
Common dividends paid in 2014 totaled $2.02b per share. The company's most significant pending event is its merger with Aviv REIT, Inc., under which each Aviv common share converts into 0.90 of an Omega share. The filing states that Omega expects to issue approximately 45.5 million common shares and 10.3 million operating partnership units in the merger, and that legacy Omega stockholders would own approximately 70% of the combined company on a fully diluted basis.
Four stockholder class actions challenging the merger have been consolidated in Maryland, and the company says it believes they have no merit. On February 9, 2015, Omega issued 10.925 million shares at $42.00c per share, with $439 million in estimated net proceeds intended to redeem its $200 million 7.50% senior notes due 2020 and repay revolver borrowings. At year-end, the company reported total assets of $3.9 billion, stockholders' equity of $1.4 billion, and debt of $2.4 billion, representing approximately 62.9% of total capitalization.
Concentration risk is notable: New Ark Investment, Inc. accounted for 13%d of total investments and 12% of 2014 revenues, and Genesis accounted for 11% of revenues. Management states that its operators can absorb moderate reimbursement rate reductions, while the filing repeatedly flags Medicare and Medicaid reimbursement pressure as a key risk to operator credit quality.
02—Key points
Key Highlights
- Total operating revenues of $504.8 million in 2014, up from $418.7 million in 2013; rental income was $388.4 million and direct financing lease income was $56.7 million.
- Net income available to common stockholders of $221.3 million ($1.74 diluted EPS) versus $172.5 million in 2013; FFO available to common stockholders of $345.4 million versus $302.7 million.
- Pending merger with Aviv REIT: 0.90 Omega share per Aviv share, with approximately 45.5 million Omega shares and 10.3 million operating partnership units expected to be issued; expected completion early in the second quarter of 2015.
- February 2015 equity offering of 10.925 million shares at $42.00 per share, with $439 million in net proceeds planned for redeeming the $200 million 7.50% senior notes due 2020 and repaying revolver borrowings.
- Portfolio of 568 facilities in 38 states with approximately $4.4 billion of gross investments, operated by 50 third-party operators; 474 SNFs, 23 ALFs and 11 specialty facilities.
- Customer concentration: New Ark Investment, Inc. represents 13% of total investments and Genesis represents 11% of 2014 revenues.
- Year-end total assets of $3.9 billion, stockholders' equity of $1.4 billion, and debt representing approximately 62.9% of total capitalization; 2014 common dividends of $2.02 per share, with a quarterly dividend raised to $0.53 in January 2015.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-KFY2014filed February 27, 2015Financial Statements
FY2014 against FY2013
| Line item | FY2014FY2013 | Change |
|---|---|---|
| Operating Expenses | $159.48M$153.03M | +4.2% |
| Operating Income | $345.31M$265.68M | +30.0% |
| Interest Expense | $119.37M$100.38M | +18.9% |
| Net Income | $221.35M$172.52M | +28.3% |
| EPS (Basic) | $1.75$1.47 | +19.0% |
| EPS (Diluted) | $1.74$1.46 | +19.2% |
| Shares Outstanding (Basic) | 126.55M117K | +107825.3% |
| Shares Outstanding (Diluted) | 127.29M118K | +107684.9% |
05—Questions
Frequently Asked Questions
What is the status of the Aviv merger and what does it mean for existing Omega shareholders?
The merger agreement was signed October 30, 2014 and was expected to close early in the second quarter of 2015, subject to conditions. Under the filing's estimate, legacy Omega stockholders would own approximately 70% of the combined company on a fully diluted basis, with former Aviv investors owning approximately 30%, so existing holders would experience dilution in ownership percentage. Four stockholder lawsuits challenging the merger were consolidated in Maryland, and a hearing on motions to dismiss was scheduled for February 27, 2015.
How is the company funding its growth and reducing its debt costs?
In 2014 Omega issued $400 million of 4.95% senior notes due 2024 and $250 million of 4.50% senior notes due 2025, and entered into a $1.2 billion unsecured credit facility in June 2014. The filing also describes the February 2015 equity offering and the planned redemption of the 7.50% 2020 notes using the net proceeds. It also states that the company sold 1.8 million shares under its equity shelf program in 2014 for gross proceeds of approximately $63.5 million.
What are the main risks tied to the company's revenue?
Revenue depends on operators' ability to pay rent and mortgage interest, and the filing highlights Medicare and Medicaid reimbursement reductions, the Healthcare Reform Law, and the American Taxpayer Relief Act cuts of approximately $600 million to SNF payments from FY 2013 to FY 2022 as significant pressures. Revenue is also concentrated: New Ark (12% of 2014 revenues) and Genesis (11%) are the largest contributors. The company says it cannot assure that operators will meet their obligations in full.
What did the company's 2014 investment activity look like?
The company completed about $566 million of new investments in 2014 according to the filing. The largest was a $415 million mortgage loan refinancing and consolidation with an existing operator covering 31 Michigan facilities at an initial 9.0% cash interest rate. Other transactions included a $112.5 million mortgage loan, an $84.2 million purchase/leaseback of four assisted living facilities, and a $34.6 million acquisition of three SNFs in Georgia and South Carolina.
How much of the company's capital structure is debt, and how is leverage described?
The filing states that debt represented approximately 62.9% of total capitalization at December 31, 2014, with debt of $2.4 billion against stockholders' equity of $1.4 billion. The company reports being in compliance with its financial covenants at year-end. The filing also notes that a one percent increase in interest rates would reduce the fair value of long-term borrowings by approximately $164 million at December 31, 2014.
06—Continue